BNP Paribas Knock-Out NKE/ DE000PF2NB28 /
27/06/2024 11:36:02 | Var.0.00 | Denaro12:29:43 | Lettera12:29:43 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.37EUR | 0.00% | 1.37 Quantità in denaro: 34,000 |
- Quantità in lettera: - |
NIKE INC. B | 80.6275 - | 31/12/2078 | Call |
GlobeNewswire
12:40
Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER Wa...
GlobeNewswire
12:30
X4 Pharmaceuticals Announces Positive Interim Clinical Data from Ongoing Six-Month Phase 2 Trial of ...
GlobeNewswire
12:30
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
GlobeNewswire
12:00
Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Inte...
GlobeNewswire
12:00
Nightfood Holdings Inc. New Subsidiary, Future Hospitality Ventures, Solves Hospitality Labor Crisis
GlobeNewswire
12:00
Action1 Achieves CSA STAR Level 1 Certification and Signs CISA's Secure by Design Pledge
GlobeNewswire
12:00
Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Ann...
GlobeNewswire
12:00
FUTUREFUEL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed A...
GlobeNewswire
12:00
GenVivo Announces Initiation of Patient Dosing in a US Phase I/Ib Clinical Trial Evaluating GEN2, a ...
GlobeNewswire
12:00
Interlock Launches ThreatSlayer Web3 Security Extension and Incentivized Crowdsourced Internet Secur...
GlobeNewswire
12:00
LanzaTech and LanzaJet Introduce CirculAir™, a Revolutionary and Commercially Ready Solution to Conv...